Evidence map›Paper›PMID 16870757›Full record

ArticleAntimicrobial agents and chemotherapy2006

Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum.

Christine Voha, Jean-Denis Docquier, Gian Maria Rossolini, Thierry Fosse

Open access · greenAbstract readComparative Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. The EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing of Oral Anaerobes.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Article
  2. Frontiers in medicine · 2025
    Article
  3. Review
  4. Article
  5. Species Delineation and Comparative Genomics within theJournal of clinical microbiology · 2023
    Review
  6. Article
  7. Article
  8. Epidemiology of β-Lactamase-Producing Pathogens.Clinical microbiology reviews · 2020
    Review
  9. Article
  10. Acquired Class D β-Lactamases.Antibiotics (Basel, Switzerland) · 2014
    Review
  11. Article
  12. Article
  13. Article
  14. Diversity, epidemiology, and genetics of class D beta-lactamases.Antimicrobial agents and chemotherapy · 2010
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Christine VohaLaboratoire de Bactériologie et Epidémiologie Moléculaire, Université de Nice, Centre Hospitalier Universitaire de Nice, France.
Jean-Denis Docquier
Gian Maria Rossolini
Thierry Fosse
Centre Hospitalier Universitaire de Nice · FRUniversity of Liège · BEUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have reported beta-lactamase-mediated penicillin resistance in Fusobacterium nucleatum, but no beta-lactamase gene has yet been identified in this species. An F. nucleatum subsp. polymorphum strain resistant to penicillin and amoxicillin was isolated from a human periodontitis sample. DNA cloning and sequencing revealed a 765-bp open reading frame encoding a new class D beta-lactamase named FUS-1 (OXA-85). A recombinant Escherichia coli strain carrying the bla(FUS-1) gene exhibited resistance to amoxicillin with a moderate decrease in the MICs with clavulanic acid. The bla(FUS-1) gene was found in two additional clonally unrelated F. nucleatum subsp. polymorphum isolates. It was located on the chromosome in a peculiar genetic environment where a gene encoding a putative transposase-like protein is found, suggesting a possible acquisition of this class D beta-lactamase gene. The FUS-1 enzyme showed the closest ancestral relationship with OXA-63 from Brachyspira pilosicoli (53% identity) and with putative chromosomal beta-lactamases of Campylobacter spp. (40 to 42% identity). FUS-1 presents all of the conserved structural motifs of class D beta-lactamases. Kinetic analysis revealed that FUS-1 exhibits a narrow substrate profile, efficiently hydrolyzing benzylpenicillin and oxacillin. FUS-1 was poorly inactivated by clavulanate and NaCl. FUS-1 is the first example of a class D beta-lactamase produced by a gram-negative, anaerobic, rod-shaped bacterium to be characterized.

Indexed as

Amino Acid SequenceAmoxicillinAnti-Bacterial AgentsBase Sequencebeta-LactamasesClavulanic AcidDrug Resistance, Multiple, BacterialEscherichia coliFusobacterium nucleatumGenes, BacterialHumansKineticsMicrobial Sensitivity TestsMolecular Sequence DataMolecular WeightOpen Reading FramesAmoxicillinAnti-Bacterial Agentsbeta-LactamasesClavulanic AcidPenicillinsSalts

Identifiers

PMID16870757
PMCPMC1538689
OpenAlexW2097753916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.